- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04248660
Uterine Artery Doppler and 11-14 / 20-22 Weeks of Gestation Pregnancy
Comparison of Uterine Artery Doppler Measurements Performed at 11-14 and 20-22 Weeks of Gestation During Pregnancy According to Delivery Type and Number of Births and Investigation of the Effects on Obstetric Outcomes (Maternal, Fetal, Neonatal Results)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 33404
- Kanuni Sultan Suleyman Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Gestational age 11-14. applying to the outpatient clinic at week
- Single spontaneous pregnancy
- Having a first pregnancy (primigravid nullipar) or having given birth once (primipar) (first birth by vaginal route or cesarean)
- Result of previous pregnancy with live birth (term delivery without obstetric complication)
- No intrauterine growth restriction in the first pregnancy
- Women who gave birth by cesarean section were not placed due to caesarean indication due to placental location-invasion anomaly, maternal chronic disease (hypertension, diabetes, coronary artery disease, etc.), placental detachment.
Exclusion Criteria:
- Multiple pregnancies
- Pregnancies with assisted reproductive techniques
- Placental anomaly in previous pregnancy
- Maternal chronic hypertension, preeclampsia, history of diabetes
- Pregnant women who smoke
- The presence of fetal chromosomal or structural anomaly
- two or more cesarean sections
- Having undergone non-cesarean surgery (myomectomy, septum or polyp resection ... etc)
- Presence of uterine structural anomaly
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Uterine artery doppler measurements
Uterine artery doppler measurements will be made in the same patients at 11-14 weeks and 20-22 weeks of pregnancy. Doppler results will be classified according to pregnancy results and primary results will be doppler findings. |
The effect of delivery type on changes in uterine blood flow will be investigated. Doppler results groups will be defined according to the effect of deviations in uterine blood flow on neonatal and perinatal results. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Doppler results of 11-14 weeks of gestation in patients with previous cesarean section
Time Frame: 10 months
|
uterine artery doppler values (uterine artery PI , presence of uterine artery notch)
|
10 months
|
|
Doppler results of 11-14 weeks of gestation in those who gave birth beforehand
Time Frame: 10 months
|
uterine artery doppler values (uterine artery PI , presence of uterine artery notch)
|
10 months
|
|
Doppler results of 20-22 weeks of gestation in patients with previous cesarean section
Time Frame: 10 months
|
uterine artery doppler values (uterine artery PI , presence of uterine artery notch)
|
10 months
|
|
Doppler results of 20-22 weeks of gestation in those who gave birth beforehand
Time Frame: 10 months
|
uterine artery doppler values (uterine artery PI , presence of uterine artery notch)
|
10 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ATADEK-2020/00
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
The University of Texas Health Science Center at...The University of Texas at San AntonioCompleted
-
Gynuity Health ProjectsCuidado Integral de la Mujer, Gineclinic, S.C.; Servicios de Salud Medieg,...Not yet recruitingPregnancy Related | Pregnancy Early
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
Université Catholique de LouvainRecruiting
-
Oregon Health and Science UniversityRecruitingPregnancy RelatedUnited States
-
Biorithm Pte LtdRecruiting
Clinical Trials on uterine artery doppler measurement
-
Second Affiliated Hospital of Wenzhou Medical UniversityNot yet recruiting
-
Ethicon, Inc.TerminatedUterine Fibroids | MenorrhagiaNetherlands, Denmark, France, Germany, Norway, Switzerland, United Kingdom
-
Benha UniversityCompleted
-
Ethicon, Inc.TerminatedUterine Fibroids | MenorrhagiaCanada, United States, Mexico
-
Haseki Training and Research HospitalCompleted
-
University of TorontoThe Physicians' Services Incorporated Foundation; Stichting Oranjekliniek,...Completed
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalRecruitingPostoperative Cognitive Dysfunction | Delirium, PostoperativeTurkey (Türkiye)
-
Istanbul UniversityUnknownUltrasonography | Anesthesia | Catheterization | Radial ArteryTurkey
-
Kasr El Aini HospitalCompletedLupus Glomerulonephritis | Systemic Lupus Erthematosus | Lupus FlareEgypt